Corrigendum to “Therapeutic drug monitoring of imipenem/cilastatin and meropenem in critically ill adult patients” [Journal of Global Antimicrobial Resistance 36 (2024) 252-259]
Xi You,
Qing Dai,
Jing Hu,
Mingjie Yu,
Xiaowen Wang,
Bangbi Weng,
Lin Cheng,
Fengjun Sun
Affiliations
Xi You
Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China
Qing Dai
Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China
Jing Hu
Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China
Mingjie Yu
Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China
Xiaowen Wang
Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China
Bangbi Weng
Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China
Lin Cheng
Corresponding author at: Lin Cheng, Department of Pharmacy, The First Affiliated Hospital of Army Medical University, Gaotanyan Street #29, Shapingba, Chongqing 400038, China.; Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China
Fengjun Sun
Alternative corresponding author.; Department of Pharmacy, The First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing, China
